Callanga, Jerlyn R.
HRN: 08-39-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/18/2023
01/25/2023
IV
170mg
Q6h
Preseptal Cellulitis, Periodontal Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes